Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Morocco
  Namibia
  Netherlands
  Norway
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


   Infocentre

Last Update: 30-04-2009  
Related category(ies):
Health & life sciences  |  Special Collections
Source: Research Headlines
Add to PDF "basket"

Researchers identify molecular link between viral infection and cancer susceptibility

A Portuguese-US research team has discovered a new molecular mechanism that enables gamma herpes viruses to chronically infect patients. Their research also offers a greater understanding of why these patients are more likely to suffer from lymphocyte (white blood cell) cancer lymphoma; this is especially evident in cases of immunodeficiency. The results of the study were published in the online edition of The EMBO Journal.

Viruses target weak immune systems © Shutterstock
Viruses target weak immune systems
© Shutterstock

The researchers' findings demonstrate that a protein from the gamma herpes viruses, called ORF73, mimics the host molecular machinery to inhibit NF-kB on infected lymphocytes. NF-kB is a protein complex that acts as a transcription factor and is involved in cellular responses to various stimuli including death and proliferation. The discovery also sheds light on how this process sets the stage for the development of lymphomas.

'The ORF73 protein from the lymphotropic gamma herpes virus MuHV-4 is a strong terminator of NF-kB-dependent transcription. Several viral proteins have been shown to interfere with the NF-kB pathway,' the authors wrote in their paper. 'The mechanism involves the assembly by ORF73 of an EC5S E3 ubiquitin-ligase. This complex targets nuclear-activated RelA for poly-ubiquitination and subsequent proteasomal degradation.'

The researchers explained that if NF-kB inhibition in gamma herpes virus-infected patients with lymphomas is confirmed, drugs capable of saving the molecule could effectively decrease the chances of someone developing lymphomas.

Gamma herpes viruses infect white blood cells (B or T lymphocytes) remaining latent in the lymphoid tissues as an asymptomatic chronic infection, but can also trigger the appearance of lymphomas. According to the researchers, gamma herpes viruses include the common Epstein-Barr virus, the causative agent of infectious mononucleosis, and Kaposi's sarcoma-associated herpes virus, a cancer affecting AIDS patients.

The relationship between chronic lymphocyte infection and lymphomas remains a mystery because there is very little information about the mechanisms behind the virus/infected lymphocytes interaction, the team explained. But they pointed out that the viral manipulation of the host molecular machinery wreaks havoc with the normal controls of the cells, which, in turn, raises the risk of cancer. According to them, this is a plausible reason because viruses cannot self-reproduce and are forced to 'hijack' the infected cells' molecular machinery so as to split away and spread infection.

'These findings demonstrate that viral inhibition of NF-kB activity in latently infected germinal centre centroblasts is critical for the establishment of a gamma herpes virus persistent infection, underscoring the physiological importance of proteasomal degradation of RelA/NF-kB as a regulatory mechanism of this signalling pathway,' the authors wrote.

Participating in the study were the Institutes of Microbiology and of Molecular Medicine at the University of Lisbon (Portugal), the Gulbenkian Science Institute (Portugal) and the Weill Medical College of Cornell University (US).


Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
1) This search is for articles in the Information Centre, i.e. this site. To search all the European Commission's research and innovation sites, use the search box at the top of the page to the right of the menu.
2) In both cases, new content may take between a few minutes to a day to be indexed by the search engine and therefore to appear in the results.
3) If after clicking on a link in the search results the page is blank, please refresh the page (press F5 or CTRL-R). This problem is limited to Internet Explorer and the way it has been installed in some organisations; you should have no problem with other browsers. We will implement a solution as soon as possible.

Print Version
Share this article
See also

The EMBO Journal
University of Lisbon
'European researchers identify more genes responsible for cancer'





  Top   Research Information Center